Xalud Therapeutics, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2009-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.xaludthera.com
Clinical Trials
8
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Safety Study of XT-150 in Participants With ALS
- Conditions
- Amyotrophic Lateral Sclerosis (ALS)
- Interventions
- First Posted Date
- 2024-11-26
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Xalud Therapeutics, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT06704347
- Locations
- 🇺🇸
Barrow Neurological Institute (St. Joseph's), Phoenix, Arizona, United States
🇺🇸Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Safety and Efficacy of XT-150 for Facet Joint Osteoarthritis Pain
- Conditions
- Facet Joint PainBack PainInflammation
- Interventions
- Biological: Placebo
- First Posted Date
- 2022-01-19
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Xalud Therapeutics, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT05196919
- Locations
- 🇺🇸
Neurovations, Napa, California, United States
🇺🇸Source HealthCare, Santa Monica, California, United States
🇺🇸Center for Clinical Research, Winston-Salem, North Carolina, United States
Preliminary Safety and Efficacy of XT-150 in Facet Joint Osteoarthritis
- Conditions
- Osteoarthritis, Spine
- First Posted Date
- 2021-04-12
- Last Posted Date
- 2022-03-17
- Lead Sponsor
- Xalud Therapeutics, Inc.
- Registration Number
- NCT04841512
- Locations
- 🇦🇺
Alfred Health, Melbourne, Victoria, Australia
Safety and Efficacy of XT-150 for Treatment of Neuropathic Pain
- Conditions
- Neuropathic Pain
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2023-01-23
- Lead Sponsor
- Xalud Therapeutics, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT04466410
- Locations
- 🇦🇺
Genesis Research Services, Newcastle, New South Wales, Australia
🇦🇺CerCare, Wayville, South Australia, Australia
🇦🇺Metro Pain Group, Clayton, Victoria, Australia
Efficacy and Safety of XT-150 in Osteoarthritis of the Knee
- First Posted Date
- 2019-10-11
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- Xalud Therapeutics, Inc.
- Target Recruit Count
- 289
- Registration Number
- NCT04124042
- Locations
- 🇺🇸
eStudySite, La Mesa, California, United States
🇺🇸Neurovations (Napa Pain Institute), Napa, California, United States
🇺🇸Source Healthcare, Santa Monica, California, United States
- Prev
- 1
- 2
- Next